Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOP reduction and ocular blood perfusion in optic disc drusen
RBR-5hjbmtxPhase 2Completed
- Sponsor
- Hospital Oftalmológico de Brasília
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of latanoprost in optic disc drusen (ODD), sponsored by Hospital Oftalmológico de Brasília. Started Aug 2021; status: completed.
02
Drugs
latanoprost
03
Conditions
optic disc drusen (ODD)
Beyond the preview
Go deeper on RBR-5hjbmtx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5hjbmtx.